BERLIN (AP) – A number of European cascades, including Germany, France, Italy and Spain, stopped using the AstraZeneca COVID-19 vaccine on Monday due to reports of blood clots in some recipients, although international regulators say no. proof that the shot was fired.
AstraZeneca formula is one of three vaccines used on the continent. But the growing concern is another setback to the EU vaccine boom, which suffers from shortcomings, other obstacles, and lags far behind Britain and the United States.
The EU Drug Enforcement Administration convened a meeting on Thursday to review experts’ findings on the AstraZeneca shooting to determine whether action was needed.
The Fur burn comes at a time when much of Europe is tightening restrictions on schools and businesses amid rising COVID-19 cases.
The German health minister said the decision to suspend AstraZeneca was made on the advice of the Paul Erlich Institute for Vaccine Regulation, which called for a further investigation into seven cases of brain thrombosis in vaccinated people.
“Today’s decision is a precautionary measure,” said Jens Spann.
French President Emmanuel Macron has announced that his country will also stop providing vaccines at least on Tuesday afternoon. Italy also announced a temporary ban, as did Spain, Portugal and Slovenia.
Other countries that have done so in the last few days are Denmark, which was the first, as well as Ireland, Thailand, the Netherlands, Norway, Iceland, Congo and Bulgaria. Canada և Britain is still standing by the vaccine.
AstraZeneca is expected to apply for the US vaccine in the coming weeks. The United States now relies on Pfizer, Moderna և Johnson & Johnson.
AstraZeneca reports that out of more than 17 million people vaccinated in 27 EU countries and Britain, there were 37 reports of blood transfusions. The pharmacist said there was no evidence that the vaccine increased the risk of blood clots.
In fact, it says that thrombosis cases are much lower than expected to occur naturally in the general population of this size, similar to other licensed COVID-19 vaccines.
The World Health Organization and the European Medicines Agency also said the data did not suggest the vaccine had caused a blood clot, that people should continue to be vaccinated.
“Many thousands of people in the EU develop blood clots every year for a variety of reasons,” said the European Medicines Agency. The incidence among vaccinated people “does not appear to be higher than in the general population.”
The agency noted that while the investigation is ongoing, “the benefits of the AstraZeneca vaccine in preventing COVID-19, as well as the risk of hospitalization and death, outweigh the risks of side effects.”
Blood tissue can pass through the body, causing heart attacks, strokes, and fatal lung blockages. AstraZeneca reported 15 cases of deep vein thrombosis or 22 cases of thrombosis-type pulmonary embolism or 22 cases of pulmonary thrombosis.
The AstraZeneca staff has become a key tool in European countries’ efforts to promote their slow-release vaccines. It is also a pillar of a UN-supported program known as COVAX, which aims to deliver COVID-19 vaccines to poorer countries. The European suspension does not affect that program.
Pfizer և Moderna vaccines are also used on the European continent, և J&J single dose vaccine has been approved but has not yet been delivered.
Dr. Michael Head, a senior global health researcher at the University of Southampton in England, said there was no evidence to support the suspension of the AstraZeneca vaccine, calling the decision “puzzling”.
“Stopping the spread of vaccines during an epidemic has consequences,” said Hed. “This leads to delays in human protection, the potential for increased vaccine suspicion as a result of people who have seen the headlines and are clearly concerned.”
German Health Minister Span defended the country’s decision, saying: “The most important thing for trust is transparency.” He said both the first and second doses would be discontinued.
Germany has received just over 3 million doses of the AstraZeneca vaccine, about half of which have been taken so far, compared with the nearly 7 million Pfizer և 285,000 cases of Moderna.
German authorities have encouraged anyone who feels worse more than four days after the shooting, such as persistent headaches or spotted bruises, to see a doctor.
The head of the Spanish Medicines Agency, Maria Jesus Lamas, said that Spain had discovered the first case of thrombosis on Saturday. He said the ban was “not an easy decision” as it further slowed the nation’s vaccination campaign, but it was the “wisest” approach.
The AstraZeneca strike hit almost 940,000 people in Spain.
At the same time, some European countries have begun to reintroduce restrictions to curb the spread of infections, many from the original virus.
In Italy, 80% of children in the country could not attend school after more rules came into force in more regions on Monday. In Poland, stricter restrictions were imposed on both regions, including Warsaw. In a few days, Paris may find itself in a dead end, as the intensive care units are filled with COVID-19 patients.
And so in Germany, alarms are rising over cases of “emergency braking.”
This report was contributed by Sylvie Corben in Paris, Maria Cheng in London, and Amy Keith in Ke և Francis D’Emilio in Rome.
Follow the AP epidemic coverage: